Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 3 of 22 | Showing Results 11 - 15 of 106

Evaluating immunologic tumor-based biomarkers in early stage breast cancer and immune-based assays as biomarkers of response to systemic therapy in breast cancer

In this study, we wish to prospectively collect peripheral blood from women with breast cancer who are treated with standard therapies (for...

David Page, M.D.
  • Providence Cancer Institute Franz Clinic

A Phase II Study of Nivolumab Combined With Bicalutamide and Ipilimumab in Metastatic HER2-negative Breast Cancer

The goal of this protocol is to evaluate the safety and efficacy of an alternative systemic combination approach that omits or delays the use of...

David Page, M.D.
  • Memorial Sloan Kettering (MSK)
  • Oncology and Hematology Care Westside
  • Providence Cancer Institute Franz Clinic

Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab (neoHIP)

A phase 2 open-label, randomized, multi-center trial to evaluate the efficacy and safety of neoadjuvant trastuzumab, pertuzumab and weekly...

David Page, M.D.
  • Oncology and Hematology Care Westside
  • Providence Cancer Institute Clackamas Clinic
  • Providence Cancer Institute Franz Clinic
  • Providence Cancer Institute Newberg Clinic

Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a...

Alison Conlin, M.D.
  • Oncology and Hematology Care Westside
  • Providence Cancer Institute Clackamas Clinic
  • Providence Cancer Institute Franz Clinic
  • Providence Cancer Institute Newberg Clinic

Biospecimen Collection from Subjects with Metastatic Breast Cancer to Evaluate the Ability to Expand Marrow T-Cells

David Page, M.D.
  • Providence Cancer Institute Franz Clinic
Viewing Page 3 of 22 | Showing Results 11 - 15 of 106